U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07224152) titled 'NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer' on Oct. 31.
Brief Summary: This is a single institution, single arm phase I/II study of NBTXR3 with radiation therapy for stage I-III advanced non-small cell lung cancer patients who are not candidates for chemotherapy or surgical resection.
Study Start Date: April 30, 2026
Study Type: INTERVENTIONAL
Condition:
Locally-Advanced Non-Small Cell Lung Cancer
Intervention:
DRUG: NBTXR3
Given by injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: M.D. Anderson Cancer Center
Published by HT Digital Content Services with permission from Healt...